Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: A prospective observational study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Nurmohamed, Shaikh A ^a   Jallah, Borefore P ^a   Vervloet, Marc G ^a   Yldirim, Gul ^a   Ter Wee, Pieter M ^a   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Citrate; Continuous venovenous haemofiltration; Efficacy; Replacement solution; Safety

Indexed keywords

AMINOTRANSFERASE; BICARBONATE; CITRIC ACID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERLACTATEMIA; INTENSIVE CARE UNIT; MALE; METABOLIC REGULATION; MORTALITY; OBSERVATIONAL STUDY; PATIENT SAFETY; PH; PROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CITRATES; FEMALE; HEMODIALYSIS SOLUTIONS; HEMOFILTRATION; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876196993     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-89     Document Type: Article

References (29)

1. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Oudemans-van Straaten HM, Kellum JA, Bellomo R, Crit Care 2011 15 202 21345279
2. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Mehta RL, McDonald BR, Aguilar MM, Ward DM, Kidney Int 1990 38 976 981 10.1038/ki.1990.300 2266683
3. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Palsson R, Niles JL, Kidney Int 1999 55 1991 1997 10.1046/j.1523-1755.1999.00444.x 10231464
4. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN, Am J Kidney Dis 2000 35 802 811 10.1016/S0272-6386(00)70248-4 10793012
5. Simplified citrate anticoagulation for continuous renal replacement therapy. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG, Kidney Int 2001 60 370 374 10.1046/j.1523-1755.2001.00809.x 11422774
6. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Hofmann RM, Maloney C, Ward DM, Becker BN, Ren Fail 2002 24 325 335 10.1081/JDI-120005366 12166699
7. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C, Intensive Care Med 2002 28 1419 1425 10.1007/s00134-002-1443-y 12373466
8. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A, Crit Care Med 2003 31 2450 2455 10.1097/01.CCM.0000084871.76568.E6 14530750
9. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR, Clin Nephrol 2003 59 106 114 12608553
10. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Bihorac A, Ross EA, Am J Kidney Dis 2005 46 908 918 10.1053/j.ajkd.2005.08.010 16253732
11. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance. Naka T, Egi M, Bellomo R, Cole L, French C, Botha J, Wan L, Fealy N, Baldwin I, Int J Artif Organs 2005 28 222 228 15818544
12. Continuous venovenous haemofiltration using a citrate buffered substitution fluid. Schmitz M, Taskaya G, Plum J, Hennersdorf M, Sucker C, Grabensee B, Hetzel GR, Anaesth Intensive Care 2007 35 529 535 18020071
13. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Durão MS, Monte JCM, Batista MC, Oliveira M, Iizuka IJ, Santos BF, Pereira VG, Cendoroglo M, Santos OFP, Crit Care Med 2008 36 3024 3029 10.1097/CCM.0b013e31818b9100 18824904
14. A safe anticoagulation protocol with variable treatment efficacy and excellent control of acid-base status. Morgera S, Schneider M, Slowinski T, Varrgas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer H-H, Crit Care Med 2009 37 2018 2024 10.1097/CCM.0b013e3181a00a92 19384210
15. Citrate anticoagulation for continuous venovenous hemofiltration. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF, Crit Care Med 2009 37 545 552 10.1097/CCM.0b013e3181953c5e 19114912
16. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC, Nephrol Dial Transplant 2011 26 232 239 10.1093/ndt/gfq575 20876598
17. Total-to ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Link A, Klingele M, Speer T, Pöss J, Lerner-Gräber A, Fliser D, Crit Care 2012 16 97 10.1186/cc11363 22643456
18. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A, Crit Care 2012 27 111
19. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD, Am J Kidney Dis 1999 33 1 4 10.1016/S0272-6386(99)70251-9 9915261
20. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T, Crit Care Med 2001 29 748 752 10.1097/00003246-200104000- 00010 11373461
21. Citrate, calcium, parathyroid hormone and anion gap in a patient with citrate intoxication during citrate based CVVH. Ter Veldhuis SMJ, Wolthuis A, Bakker AJ, Van der Voort PHJ, Neth J Crit Care 2006 10 74 76
22. Severe metabolic alkalosis complicating regional citrate hemodialysis. Kelleher SP, Schulman G, Am J Kidney Dis 1987 IX 235 236
23. Metabolic alkalosis induced by regional citrate hemodialysis. Silverstein FJ, Oster JR, Perez GO, Materson BJ, Lopez RA, Al-Reshaid K, ASAIO Trans 1989 35 22 25 2730806
24. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Thoenen M, Schmid ER, Binswanger U, Schuepbach R, Aerne D, Schmidlin D, Wien Klin Wochenschr 2002 114 108 114 12060967
25. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB, Blood Purif 2007 25 316 323 10.1159/000107045 17700015
26. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB, J Crit Care 2010 25 120 127 10.1016/j.jcrc.2009.02.013 19427760
27. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW, Am J Kidney Dis 2012 59 810 818 10.1053/j.ajkd.2011.11.030 22226564
28. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Zhang Z, Hongying N, Intensive Care Med 2012 38 20 28 10.1007/s00134-011-2438-3 22124775
29. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin. Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld AB, ASAIO J 2011 57 48 52 10.1097/MAT.0b013e318201a599 21084966